Superior 125-month outcome through cetuximab in the larynx organ preservation trial DeLOS-II: a single study center's experience.

Wichmann G, Wald T, Zebralla V, Stoehr M, Pirlich M, Wiegand S, Kunz V, Dietz A

DOI: 10.3389/fonc.2024.1506840
Published: 2024
Container: Frontiers in oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2024.1506840,
  title = {Superior 125-month outcome through cetuximab in the larynx organ preservation trial DeLOS-II: a single study center's experience.},
  author = {Wichmann G and Wald T and Zebralla V and Stoehr M and Pirlich M and Wiegand S and Kunz V and Dietz A},
  year = {2024},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2024.1506840},
  url = {https://doi.org/10.3389/fonc.2024.1506840}
}

RIS

TY  - JOUR
TI  - Superior 125-month outcome through cetuximab in the larynx organ preservation trial DeLOS-II: a single study center's experience.
AU  - Wichmann G
AU  - Wald T
AU  - Zebralla V
AU  - Stoehr M
AU  - Pirlich M
AU  - Wiegand S
AU  - Kunz V
AU  - Dietz A
PY  - 2024
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2024.1506840
UR  - https://doi.org/10.3389/fonc.2024.1506840
ER  -

APA

G, W., T, W., V, Z., M, S., M, P., S, W., V, K., & A, D. (2024). Superior 125-month outcome through cetuximab in the larynx organ preservation trial DeLOS-II: a single study center's experience.. Frontiers in oncology. https://doi.org/10.3389/fonc.2024.1506840

Source records

pubmed · retrieved 2026-09-25T12:26:40.744Z